Building a Strong European Health Union: Blazing a trail in the European pharmaceutical sector
The start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global
Read moreThe start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global
Read moreIntroduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read moreAs discussions surrounding the revision of the EU pharmaceutical legislation take place, two fundamental questions come to the forefront: how
Read moreSince 2020, the COVID pandemic altered every part of our lives, our societies, and our economies. It caught the world
Read moreThe COVID-19 crisis has pushed health higher on the agenda of the European Union, but also on the list of
Read moreA lot has changed in the last two years. The pandemic and the war in Ukraine have made us feel
Read moreGovernments can exercise their power in two main ways: on the one hand, by imposing rules and regulations, and on
Read moreThe race is on. Countries all over the world are competing for new technology to protect their industries, while mitigating
Read more